📣 VC round data is live. Check it out!

Quantum-Si Valuation Multiples

Discover Quantum-Si's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova and more.

Quantum-Si Overview

About Quantum-Si

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.


Founded

2013

HQ

United States

Employees

149

Financials (LTM)

Revenue: $2M
EBITDA: ($85M)

EV

$143M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Quantum-Si Financials

Quantum-Si reported last 12-month revenue of $2M and negative EBITDA of ($85M).

In the same LTM period, Quantum-Si generated $783K in gross profit, ($85M) in EBITDA losses, and had net loss of ($100M).

Revenue (LTM)


Quantum-Si P&L

In the most recent fiscal year, Quantum-Si reported revenue of $2M and EBITDA of ($81M).

Quantum-Si is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of (3313%), and net margin of (4160%).

See analyst estimates for Quantum-Si
LTMLast FY202320242025202620272028
Revenue$2M$2M$1M$3M$2M
Gross Profit$783K$1M$488K$2M$1M
Gross Margin42%47%45%52%47%
EBITDA($85M)($81M)($92M)($104M)($93M)
EBITDA Margin(4624%)(3313%)(8485%)(3400%)(3814%)
EBIT Margin(5903%)(3997%)(10275%)(3551%)(3997%)
Net Profit($100M)($101M)($96M)($101M)($101M)
Net Margin(5444%)(4160%)(8869%)(3303%)(4160%)

Financial data powered by Morningstar, Inc.

Quantum-Si Stock Performance

Quantum-Si has current market cap of $267M, and enterprise value of $143M.

Market Cap Evolution


Quantum-Si's stock price is $1.22.

Quantum-Si share price increased by 2.5% in the last 30 days, and decreased by 37.5% in the last year.

Quantum-Si has an EPS (earnings per share) of $-0.47.

See more trading valuation data for Quantum-Si
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$143M$267M3.8%2.5%58.3%-37.5%$-0.47

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Quantum-Si Valuation Multiples

Quantum-Si trades at 77.6x EV/Revenue multiple, and (1.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Quantum-Si

EV / Revenue (LTM)


Quantum-Si Financial Valuation Multiples

As of June 3, 2026, Quantum-Si has market cap of $267M and EV of $143M.

Quantum-Si has a P/E ratio of (2.7x).

LTMLast FY202320242025202620272028
EV/Revenue77.6x58.8x132.3x46.8x58.8x
EV/EBITDA(1.7x)(1.8x)(1.6x)(1.4x)(1.5x)
EV/EBIT(1.3x)(1.5x)(1.3x)(1.3x)(1.5x)
EV/Gross Profit182.7x124.1xn/m89.5x124.1x
P/E(2.7x)(2.6x)(2.8x)(2.6x)(2.6x)
EV/FCF-(1.5x)(1.4x)(1.5x)(1.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Quantum-Si Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Quantum-Si Margins & Growth Rates

Quantum-Si decreased revenue by 58% but EBITDA grew by 13% in the last fiscal year.

In the most recent fiscal year, Quantum-Si reported gross margin of 47%, EBITDA margin of (3313%), and net margin of (4160%).

See estimated margins and future growth rates for Quantum-Si

Quantum-Si Margins

Last FY202420252026202720282029
Gross Margin47%52%47%28%
EBITDA Margin(3313%)(3400%)(3814%)(8866%)
EBIT Margin(3997%)(3551%)(3997%)(9578%)
Net Margin(4160%)(3303%)(4160%)(9597%)
FCF Margin(3992%)(3023%)(3992%)-

Quantum-Si Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(58%)183%(20%)(58%)
Gross Profit Growth(75%)228%(28%)(75%)
EBITDA Growth13%13%(11%)(2%)
EBIT Growth2%(2%)(10%)2%
Net Profit Growth(2%)5%0%(2%)
FCF Growth-(7%)5%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Quantum-Si Operational KPIs

Quantum-Si's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.

Quantum-Si's Rule of 40 is (8924%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Quantum-Si's Rule of X is (9010%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Quantum-Si
LTMLast FY202320242025202620272028
Rule of 40(4471%)(8924%)---
Bessemer Rule of X(4242%)(9010%)---
Revenue per Employee-$0.0M---
Opex per Employee-$0.7M---
S&M Expenses to Revenue3115%2207%--2207%
R&D Expenses to Revenue3072%2207%6195%1950%2207%
Opex to Revenue-4044%10320%3603%4044%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Quantum-Si Competitors

Quantum-Si competitors include OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova, Carvolix, Ascom, Median Technologies, Dong-A ST, Shoulder Innovations and Stratec.

Most Quantum-Si public comparables operate across Medical Devices, Life Sciences Tools, DeepTech, HealthTech and Quantum Computing.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
OraSure1.0x0.9x(2.7x)(2.7x)
Eurobio Scientific1.3x1.3x7.8x7.3x
Carlsmed3.9x3.2x(7.1x)(6.4x)
Alpha Teknova7.1x6.8x(42.8x)(39.5x)
Carvolix57.0x401.8x(19.6x)(12.8x)
Ascom0.7x0.7x5.9x6.0x
Median Technologies9.3x8.8x(13.7x)(13.8x)
Dong-A ST0.8x0.8x11.0x10.4x

This data is available for Pro users. Sign up to see all Quantum-Si competitors and their valuation data.

Start Free Trial

Acquisitions by Quantum-Si

Quantum-Si has acquired 1 company to date.

Last acquisition by Quantum-Si was on November 9th 2021. Quantum-Si acquired Majelac Technologies for $10M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Quantum-Si

Majelac Technologies
Description
Majelac Technologies is an Italian firm specializing in assembly equipment for the semiconductor sector, including die bonders and wafer handling systems. Based in Milan area, it supplies precision machinery to fabs in Europe and Asia for high-volume production of chips used in automotive and consumer electronics.
HQ CountryUnited States
HQ City
Philadelphia, PA
Deal Date9 Nov 2021
Valuation$10M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Quantum-Si acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Quantum-Si

Who are competitors of Quantum-Si?Quantum-Si main competitors include OraSure, Eurobio Scientific, Carlsmed, Alpha Teknova, Carvolix, Ascom, Median Technologies, Dong-A ST, Shoulder Innovations, Stratec.

See public comps similar to Quantum-Si

Lists including Quantum-Si

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial